{"id":640970,"date":"2026-01-04T19:26:10","date_gmt":"2026-01-04T19:26:10","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/640970\/"},"modified":"2026-01-04T19:26:10","modified_gmt":"2026-01-04T19:26:10","slug":"les-promesses-des-therapies-personnalisees-contre-le-cancer","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/640970\/","title":{"rendered":"les promesses des th\u00e9rapies personnalis\u00e9es contre le cancer"},"content":{"rendered":"<p>    La survie \u00e0 cinq ans d\u00e9passe d\u00e9sormais 65 % tous cancers confondus en France, contre environ 30 % au milieu du XXe si\u00e8cle.<br \/>\n                YURIMA \/ stock.adobe.com<\/p>\n<p>\n    <strong>D\u00c9CRYPTAGE &#8211;<\/strong> Les progr\u00e8s technologiques nous conduisent doucement vers une prise en charge individualis\u00e9e.<\/p>\n<p class=\"fig-paragraph\">En mati\u00e8re de cancer, les donn\u00e9es \u00e9pid\u00e9miologiques n\u2019invitent gu\u00e8re \u00e0 l\u2019optimisme. Le nombre de nouveaux cas a en effet quasiment doubl\u00e9 en France depuis 1990, pour atteindre environ 433\u00a0000 diagnostics en 2023. \u00ab\u00a0Quand on analyse pr\u00e9cis\u00e9ment les donn\u00e9es d\u2019incidence, on constate n\u00e9anmoins qu\u2019environ la moiti\u00e9 de cette hausse des cancers tient au vieillissement de la population et aux progr\u00e8s contre d\u2019autres maladies, souligne Alain Puisieux, pr\u00e9sident du directoire de l\u2019Institut Curie. Un quart est d\u00fb au d\u00e9veloppement du d\u00e9pistage et du diagnostic pr\u00e9coce, et le dernier quart \u00e0 une v\u00e9ritable augmentation de fr\u00e9quence de certains cancers, li\u00e9e notamment aux modes de vie, \u00e0 l\u2019alimentation et au comportement.\u00a0\u00bb<\/p>\n<p class=\"fig-paragraph\">Et les avanc\u00e9es scientifiques sont pleines d\u2019espoir. Il y a quelques d\u00e9cennies, un diagnostic de cancer \u00e9quivalait \u00e0 une condamnation presque certaine. Puis sont arriv\u00e9s les premiers traitements modernes. La chirurgie, d\u2019abord, a permis de prolonger la vie de nombreux malades. La\u2026<\/p>\n<p class=\"fig-premium-paywall__infos\">\n        Cet article est r\u00e9serv\u00e9 aux abonn\u00e9s.        Il vous reste 88% \u00e0 d\u00e9couvrir.\n    <\/p>\n<p>                <img  data- alt=\"Le Figaro\" class=\"fig-img--complete fig-img\"\/><\/p>\n<p class=\"fig-premium-paywall__title\">Vous avez envie de lire la suite ?<\/p>\n<p class=\"fig-premium-paywall__subtitle\">D\u00e9bloquez tous les articles imm\u00e9diatement.<\/p>\n<p class=\"fig-premium-paywall__connect\">\n                D\u00e9j\u00e0 abonn\u00e9\u00a0?                <a class=\"fig-premium-paywall__connect-link\" href=\"https:\/\/connect.lefigaro.fr\/login?client=sante_web&amp;type=main&amp;redirect_uri=https%3A%2F%2Fsante.lefigaro.fr%2Fmedecine%2Fnous-avons-deja-de-nombreux-outils-efficaces-les-promesses-des-therapies-personnalisees-contre-le-cancer-20260104\" data-js-gtm=\"{&quot;customCategorie&quot;: &quot;conversion&quot;, &quot;customAction&quot;: &quot;before_Landing_Connexion_paywall_auto&quot;, &quot;customLabel&quot;: &quot;c2FudGUubGVmaWdhcm8uZnJfXzFmMGRmNThiLTgzMGEtNjg4MC1hOWI3LTk3ODYzZGQzY2I3Ml9fQXJ0aWNsZQ==_\u00abNous avons d\u00e9j\u00e0 de nombreux outils efficaces\u00bb\u00a0: les promesses des th\u00e9rapies personnalis\u00e9es contre le cancer_278&quot;, &quot;customIDSPE&quot;: &quot;c2FudGUubGVmaWdhcm8uZnJfXzFmMGRmNThiLTgzMGEtNjg4MC1hOWI3LTk3ODYzZGQzY2I3Ml9fQXJ0aWNsZQ==&quot;, &quot;event&quot;: &quot;customEventSPE&quot;}\" target=\"_blank\" rel=\"noopener\"><br \/>\n                    Connectez-vous<br \/>\n                <\/a>\n            <\/p>\n","protected":false},"excerpt":{"rendered":"La survie \u00e0 cinq ans d\u00e9passe d\u00e9sormais 65 % tous cancers confondus en France, contre environ 30 %&hellip;\n","protected":false},"author":2,"featured_media":640971,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[237,101,232,231,234,228,1011,27,72,239,230,238,226,224,225,233,229,236,235,71,227],"class_list":{"0":"post-640970","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-actualite-sur-les-maladies","9":"tag-cancer","10":"tag-cardiologie","11":"tag-cerveau","12":"tag-diabete","13":"tag-diagnostic","14":"tag-fr","15":"tag-france","16":"tag-health","17":"tag-info-sur-les-maladies","18":"tag-infographie","19":"tag-information-sur-les-maladies","20":"tag-maladie","21":"tag-medecine","22":"tag-medicament","23":"tag-obesite","24":"tag-pathologie","25":"tag-pediatrie","26":"tag-psychiatrie","27":"tag-sante","28":"tag-traitement"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115838476893164260","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/640970","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=640970"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/640970\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/640971"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=640970"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=640970"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=640970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}